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Today’s Topics


Policies and guidance that surround study
conduct



Study closure



Tips for Study Conduct

HRPO Guidance that helps with
study conduct


Investigator’s Assurance of Commitment
to Responsible Research



Notification guideline



Consent Guidance

Approvals & Change of PI


Approval by IRB
◦ No changes in the conduct without prior IRB
approval



Change in PI
◦ If you are leaving WU and still need access to
individually identifiable information, change
the PI

Education Requirements


Anyone that helps you with individually
identifiable information or consenting
participants needs to be added via a
modification and must take CITI.



If PHI is being used, these individuals need
HIPAA training as well.
◦ PHI = private health information that comes
out of or is put into a medical record

Exempt Status


Only the IRB can grant this.



If there is a change or unanticipated
problem, send in the modification or
notification.

Exempt Studies


You may only look at information that
was put in the medical chart before the
date of IRB approval.



You may not extract any individually
identifiable information.



There is no follow-up.

Final Report


Closes the study
◦ No more access to individually identifiable
information



What is kept?
◦ All source documents in their original form –
where information was first recorded
including consent documents
◦ Must be kept for at least 6 years after study
closure

BEFORE YOU CLOSE YOUR
STUDY:


All data cleaning and auditing must be completed, including queries
from the sponsor.



Be sure that all currently planned data analyses being conducted by
WU investigators have been completed
OR
If data will continue to be used for research purposes at this time, it
has been anonymized (All identifiers and links to identifiers have been
removed/destroyed – EXCEPT consent documentation must be kept
in accordance with HRPO record retention policy.You should remove
information in the data that would link the data to the consent
document.)
◦ NOTE: If you don’t currently have plans to use/analyze the data but wish to keep
identifiers, you should close the current study and submit a NEW IRB project for
review and approval when you are ready to conduct further analyses.

BEFORE YOU CLOSE YOUR
STUDY:


Review the research record to confirm that all
reporting requirements were met as defined by
HRPO Policies and Procedures and Reporting
Guidelines.



Consider plans for record retention. Records must
be kept in their original format for at least 6 years
from the completion of the study. There may be
additional retention requirements from applicable
federal or state laws or at the request of the study
sponsor.



Review your IRB approval to determine if you need
to destroy identifiers associated with PHI.

HIPAA Minimum Necessary


Only extract data you are approved to
extract for the study.



Only access records you are approved to
access based on the IRB submission.



Only share with those you are approved to
share with, e.g. research team.



Only share in the manner approved based
on your IRB submission.

Informed Consent


Consent all participants using the method
approved in the IRB submission.
◦ Written consent means a signature on a consent
form.
 If a non-English speaking participant presents and you
want to enroll that person into a study that uses
written consent, you need a written consent
document in the native language.

◦ Waiver of consent means no one is consented.
 Therefore, there is no follow-up.

No Grace Period


Studies may only stay open for a period of
exactly 12 months.
◦ Send in renewals at least 6 weeks prior to
expiration to ensure timely renewal of your
study.



Once the study expires, all activity with
including data analysis must cease until
the study is renewed again.

Non-Compliance


Not abiding by Federal regulations,
institutional policies or guidance
◦ This can include State Statues if they apply to
your study.

Record Retention


All information generated as part of a
research study is the property of WU
◦ If you leave and you want to take copies with
you, you must get permission from your
department.



All PHI must be kept behind two locked
doors
◦ Get any electronic devices used for research
verified by your HIPAA security liaison to
ensure it meets WU standards

Recruitment of Participants


Use warm contacts to recruit participants



If you do not have a clinical need to be in
someone’s medical record, apply for a partial
waiver of authorization.
◦ This is separate from the Waiver of Consent,
consent document or other form of consent.



If you want to recruit from your department,
you must do so in a general way such as a
IRB approved departmental e-mail.

Recruitment


Have all recruitment materials and modes
of recruitment approved by the IRB.
◦ Provides information about the study or
changes in study procedures



HRPO does not need to see:
◦ Reminder cards
◦ Birthday cards

Reporting of Events


Report events listed on the front page of
the Notification Guideline found at:
http://hrpohome.wustl.edu/study_team/gu
idelines.aspx

1. Changes in the status of the study due to safety concerns
(such as a suspension or closure of enrollment)
2. Adverse Events:
A. Internal Adverse Events and External Adverse Events occurring
in the same study if they are:
o Serious (regardless of expectedness or relatedness) or;
o Unexpected and reasonably related (regardless of
seriousness)
B. External Adverse Events occurring in a different study if:
o the adverse event places the participant(s) at a greater risk
of harm than was previously known or recognized
3. Unanticipated Adverse Device Experiences (UADEs)
4. Protocol Deviations (formerly Violations/Errors and
Exceptions)

5. Complex Complaints
6. Breaches of Confidentiality
7. Audit/Inspection/Inquiry
8. Participant Incarceration
9. New Information (Safety Monitoring, Data Safety
Monitoring Board (DSMB) or Data Monitoring
Committee (DMC) reports, interim analysis reports,
progress reports or any event or new information
that suggests the research places participants or
others at a greater risk of harm than was previously
known or recognized)

Consent Guidance


Gives information on who may obtain
consent
◦ Qualified and trained members of the research
team



Who may give consent
◦ Adults (18 years and older in MO)
◦ Legally Authorized Individuals
 Not Foster Parents but Case Managers

◦ Emancipated Minors

http://hrpohome.wustl.edu/study_team/guidel
ines.aspx

TIPS for Study Conduct


Develop Source Documents to be used for
data collection
◦ Examples can be found at
http://hsrqa.wustl.edu/default_files/Page514.htm

Keep delegation logs
http://hsrqa.wustl.edu/default_files/Page982.ht
m


TIPS for Study Conduct


Keep copies of all engaged members CITI
and HIPAA training
◦ If needed for the study, keep copies of
licensure



Follow your protocol
◦ If you want to make a change, get IRB
approval

TIPS for Study Conduct


Limit the number of individuals who have
access to individually identifiable
information



Only collect what you are approved to
collect



Chart reviews are human subjects
research

TIPS for Study Conduct


Do not transmit PHI via e-mail without
written authorization to do so



Do not recruit populations or use
recruitment methods that have not been
IRB approved

What comes with your IRB
approval?


Permission to publish de-identified
information



Permission to analyze data for research
purposes

Questions


Contact HRPO at any point with any
questions you may have
314-633-7400
http://hrpohome.wustl.edu

